Evidence map›Paper›PMID 41640602›Full record

ArticleFrontiers in molecular biosciences2025

Gene expression profiling identifies ferroptosis-related genes and pathways in human colon cancers cell lines.

M Balik-Meisner, D Phadke, D Mav, R Shah, K R Shockley, Carri Murphy, Erik J Tokar, Birandra K Sinha

Abstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

M Balik-MeisnerSciome LLC, Durham, NC, United States.
D PhadkeSciome LLC, Durham, NC, United States.
D MavSciome LLC, Durham, NC, United States.
R ShahSciome LLC, Durham, NC, United States.
K R ShockleyBiostatistics and Computational Biology Branch, Division of Intramural Research, National Institutes of Environmental Health Sciences, NIH, Durham, NC, United States.
Carri MurphyMechanistic Toxicology Branch, Division of Translational Toxicology, National Institutes of Environmental Health Sciences, NIH, Durham, NC, United States.
Erik J TokarMechanistic Toxicology Branch, Division of Translational Toxicology, National Institutes of Environmental Health Sciences, NIH, Durham, NC, United States.
Birandra K SinhaMechanistic Toxicology Branch, Division of Translational Toxicology, National Institutes of Environmental Health Sciences, NIH, Durham, NC, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Colorectal cancer (CRC) is the third most diagnosed cancer worldwide and the second leading cause of cancer-related deaths. A major challenge in CRC treatment is drug resistance, which limits the efficacy of conventional therapies. Ferroptosis, an iron-dependent form of regulated cell death driven by the accumulation of reactive oxygen species (ROS), has emerged as a promising therapeutic strategy. Erastin (ER), a small-molecule compound, induces ferroptosis through ROS accumulation. Methods: We performed microarray gene expression analysis on two CRC cell lines, HCT116 and HT-29, to examine the transcriptional response to ER exposure and identify differentially expressed genes and pathways involved in ER-induced ferroptosis. Results: Our gene expression analysis revealed distinct transcriptional profiles between the two cell lines, and 26 transcripts commonly enriched in response to ER treatment were identified in both HCT116 and HT-29 cells. Notably, several of these genes-including Conclusion: Our findings highlight

Indexed as

biomarker genescolon cancererastinferroptosispathway analysis

Identifiers

PMID41640602
PMCPMC12865207

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.